KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables RefundsShares IssuedShares OutstandingShares Repurchased
Ratios

Sarepta Therapeutics (SRPT) Long-Term Debt Issuances (2017 - 2018)

Historic Long-Term Debt Issuances for Sarepta Therapeutics (SRPT) over the last 4 years, with Q4 2018 value amounting to $18.2 million.

  • Sarepta Therapeutics' Long-Term Debt Issuances fell 9664.13% to $18.2 million in Q4 2018 from the same period last year, while for Dec 2023 it was $18.2 million, marking a year-over-year decrease of 7096.84%. This contributed to the annual value of $1.1 billion for FY2022, which is N/A changed from last year.
  • As of Q4 2018, Sarepta Therapeutics' Long-Term Debt Issuances stood at $18.2 million, which was down 9664.13% from $44.4 million recorded in Q3 2018.
  • In the past 5 years, Sarepta Therapeutics' Long-Term Debt Issuances registered a high of $540.4 million during Q4 2017, and its lowest value of -$133000.0 during Q3 2015.
  • For the 3-year period, Sarepta Therapeutics' Long-Term Debt Issuances averaged around $110.9 million, with its median value being $44.4 million (2018).
  • Data for Sarepta Therapeutics' Long-Term Debt Issuances shows a peak YoY increase of 9664.13% (in 2018) and a maximum YoY decrease of 9664.13% (in 2018) over the last 5 years.
  • Quarter analysis of 3 years shows Sarepta Therapeutics' Long-Term Debt Issuances stood at $399000.0 in 2015, then soared by 135333.58% to $540.4 million in 2017, then plummeted by 96.64% to $18.2 million in 2018.
  • Its Long-Term Debt Issuances was $18.2 million in Q4 2018, compared to $44.4 million in Q3 2018 and $77.1 million in Q2 2018.